These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38395521)

  • 21. (2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice.
    Yamaguchi JI; Toki H; Qu Y; Yang C; Koike H; Hashimoto K; Mizuno-Yasuhira A; Chaki S
    Neuropsychopharmacology; 2018 Aug; 43(9):1900-1907. PubMed ID: 29802366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of (
    Highland JN; Morris PJ; Zanos P; Lovett J; Ghosh S; Wang AQ; Zarate CA; Thomas CJ; Moaddel R; Gould TD
    J Psychopharmacol; 2019 Jan; 33(1):12-24. PubMed ID: 30488740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroxynorketamine Pharmacokinetics and Antidepressant Behavioral Effects of (2
    Highland JN; Morris PJ; Konrath KM; Riggs LM; Hagen NR; Zanos P; Powels CF; Moaddel R; Thomas CJ; Wang AQ; Gould TD
    ACS Chem Neurosci; 2022 Feb; 13(4):510-523. PubMed ID: 35113535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of ketamine action as an antidepressant.
    Zanos P; Gould TD
    Mol Psychiatry; 2018 Apr; 23(4):801-811. PubMed ID: 29532791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prelimbic cortex miR-34a contributes to (2R,6R)-hydroxynorketamine-mediated antidepressant-relevant actions.
    Ye L; Xiao X; Xu Y; Zheng C; Chen S; Luo T; Li Z; Du Y; Yuan Y; Li L; Liu B; Qin W; Chou D
    Neuropharmacology; 2022 May; 208():108984. PubMed ID: 35131296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ketamine metabolite (2R,6R)-hydroxynorketamine reverses behavioral despair produced by adolescent trauma.
    Elmer GI; Tapocik JD; Mayo CL; Zanos P; Gould TD
    Pharmacol Biochem Behav; 2020 Sep; 196():172973. PubMed ID: 32569786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine.
    Shirayama Y; Hashimoto K
    Int J Neuropsychopharmacol; 2018 Jan; 21(1):84-88. PubMed ID: 29155993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. (2R,6R)-hydroxynorketamine rapidly potentiates optically-evoked Schaffer collateral synaptic activity.
    Riggs LM; Thompson SM; Gould TD
    Neuropharmacology; 2022 Aug; 214():109153. PubMed ID: 35661657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NMDA Receptor Activation-Dependent Antidepressant-Relevant Behavioral and Synaptic Actions of Ketamine.
    Zanos P; Brown KA; Georgiou P; Yuan P; Zarate CA; Thompson SM; Gould TD
    J Neurosci; 2023 Feb; 43(6):1038-1050. PubMed ID: 36596696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antinociceptive and Analgesic Effects of (2
    Yost JG; Wulf HA; Browne CA; Lucki I
    J Pharmacol Exp Ther; 2022 Sep; 382(3):256-265. PubMed ID: 35779947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive Impairment That Is Induced by (R)-Ketamine Is Abolished in NMDA GluN2D Receptor Subunit Knockout Mice.
    Ide S; Ikekubo Y; Mishina M; Hashimoto K; Ikeda K
    Int J Neuropsychopharmacol; 2019 Jul; 22(7):449-452. PubMed ID: 31135879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ketamine and its metabolite, (2R,6R)-HNK, restore hippocampal LTP and long-term spatial memory in the Wistar-Kyoto rat model of depression.
    Aleksandrova LR; Wang YT; Phillips AG
    Mol Brain; 2020 Jun; 13(1):92. PubMed ID: 32546197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Target deconvolution studies of (2R,6R)-hydroxynorketamine: an elusive search.
    Bonaventura J; Gomez JL; Carlton ML; Lam S; Sanchez-Soto M; Morris PJ; Moaddel R; Kang HJ; Zanos P; Gould TD; Thomas CJ; Sibley DR; Zarate CA; Michaelides M
    Mol Psychiatry; 2022 Oct; 27(10):4144-4156. PubMed ID: 35768639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ketamine metabolite (2R,6R)-hydroxynorketamine enhances aggression via periaqueductal gray glutamatergic transmission.
    Ye L; Ko CY; Huang Y; Zheng C; Zheng Y; Chou D
    Neuropharmacology; 2019 Oct; 157():107667. PubMed ID: 31207251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressant actions of ketamine engage cell-specific translation via eIF4E.
    Aguilar-Valles A; De Gregorio D; Matta-Camacho E; Eslamizade MJ; Khlaifia A; Skaleka A; Lopez-Canul M; Torres-Berrio A; Bermudez S; Rurak GM; Simard S; Salmaso N; Gobbi G; Lacaille JC; Sonenberg N
    Nature; 2021 Feb; 590(7845):315-319. PubMed ID: 33328636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of (2R,6R)-hydroxynorketamine in assays of acute pain-stimulated and pain-depressed behaviors in mice.
    Hillhouse TM; Partridge KJ; Garrett PI; Honeycutt SC; Porter JH
    PLoS One; 2024; 19(4):e0301848. PubMed ID: 38640139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (2R,6R)-hydroxynorketamine rapidly potentiates hippocampal glutamatergic transmission through a synapse-specific presynaptic mechanism.
    Riggs LM; Aracava Y; Zanos P; Fischell J; Albuquerque EX; Pereira EFR; Thompson SM; Gould TD
    Neuropsychopharmacology; 2020 Jan; 45(2):426-436. PubMed ID: 31216563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Pharmacological Evaluation of the Analgesic Effect and Hippocampal Protein Modulation of the Ketamine Metabolite (2R,6R)-Hydroxynorketamine in Murine Pain Models.
    Das V; Basovich MB; Thomas CJ; Kroin JS; Buvanendran A; McCarthy RJ
    Anesth Analg; 2024 May; 138(5):1094-1106. PubMed ID: 37319016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydroxynorketamine Blocks
    Abbott JA; Popescu GK
    Mol Pharmacol; 2020 Sep; 98(3):203-210. PubMed ID: 32606205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression.
    Farmer CA; Gilbert JR; Moaddel R; George J; Adeojo L; Lovett J; Nugent AC; Kadriu B; Yuan P; Gould TD; Park LT; Zarate CA
    Neuropsychopharmacology; 2020 Jul; 45(8):1398-1404. PubMed ID: 32252062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.